(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 54.75%-75.34K | -25.59%-111.33K | 26.96%-358.75K | 18.36%-95.36K | 91.97%-8.25K | -36.77%-166.49K | 40.85%-88.65K | -100.79%-491.15K | -254.10%-116.81K | 67.93%-102.75K |
Net income from continuing operations | 50.12%-49.83K | 81.64%-17.44K | 11.17%-405.44K | -1.57%-126.69K | 6.68%-83.87K | 6.94%-99.89K | 29.37%-94.99K | 79.96%-456.43K | 29.53%-124.73K | 95.72%-89.87K |
Asset impairment expenditure | ---- | ---- | 27.40%2.6K | --2.6K | ---- | ---- | ---- | --2.04K | --0 | ---- |
Remuneration paid in stock | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -93.53%18.28K | --0 | --0 |
Change In working capital | 61.70%-25.51K | -1,581.94%-93.9K | 180.09%44.09K | 262.59%28.73K | 606.84%75.62K | -362.69%-66.6K | 118.83%6.34K | -133.83%-55.04K | -95.58%7.92K | 10.04%-14.92K |
-Change in receivables | -1,146.82%-13.53K | -106.26%-907 | 1,462.24%14.14K | 101.15%29 | -57.86%708 | -5,266.67%-1.09K | 7,099.03%14.49K | 92.56%-1.04K | -31.94%-2.53K | 113.97%1.68K |
-Change in prepaid assets | 31.14%1.4K | -87.21%1.4K | 197.02%9.63K | 11.63%-3.82K | 117.57%1.44K | -18.00%1.07K | 741.69%10.94K | -120.97%-9.92K | -108.06%-4.32K | -29.85%-8.2K |
-Change in payables and accrued expense | 79.90%-13.38K | -394.33%-94.39K | 146.09%20.32K | 120.04%32.52K | 974.65%73.47K | -323.67%-66.58K | 45.04%-19.09K | -134.09%-44.08K | -88.41%14.78K | -578.91%-8.4K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 54.75%-75.34K | -25.59%-111.33K | 26.96%-358.75K | 18.36%-95.36K | 91.97%-8.25K | -36.77%-166.49K | 40.85%-88.65K | -100.79%-491.15K | -254.10%-116.81K | 67.93%-102.75K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -2,571.95%-54.48K | -161.01%-1.03K | 99.54%-1.1K | -88.95%1.66K | -1,671.24%-2.4K | 99.10%-2.04K | 107.11%1.69K | -439.59%-236.09K | -87.51%15.01K | 100.30%153 |
Net PPE purchase and sale | ---- | -161.01%-1.03K | 91.20%-1.1K | -88.95%1.66K | ---- | ---- | 107.11%1.69K | 88.59%-12.44K | 125.70%15.01K | 100.30%153 |
Net investment purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---223.65K | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -2,571.95%-54.48K | -161.01%-1.03K | 99.54%-1.1K | -88.95%1.66K | -1,671.24%-2.4K | 99.10%-2.04K | 107.11%1.69K | -439.59%-236.09K | -87.51%15.01K | 100.30%153 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Cash from discontinued financing activities | ||||||||||
Net cash flow | ||||||||||
Beginning cash position | -60.53%251.25K | -49.74%363.62K | -50.13%723.46K | -44.58%457.32K | -49.56%467.97K | -50.16%636.5K | -50.13%723.46K | --1.45M | -45.23%825.26K | --927.85K |
Current changes in cash | 22.97%-129.82K | -29.21%-112.36K | 50.52%-359.85K | 7.95%-93.7K | 89.61%-10.66K | 51.74%-168.53K | 49.92%-86.96K | -150.13%-727.24K | -81.33%-101.8K | ---102.6K |
End cash Position | -74.05%121.43K | -60.53%251.25K | -49.74%363.62K | -49.74%363.62K | -44.58%457.32K | -49.56%467.97K | -50.16%636.5K | -50.13%723.46K | -50.13%723.46K | -45.23%825.26K |
Free cash from | 55.37%-74.31K | -26.75%-112.36K | 28.54%-359.85K | 7.95%-93.7K | 89.27%-11.01K | -32.59%-166.49K | 48.95%-88.65K | -42.40%-503.59K | -685.07%-101.8K | 72.35%-102.6K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data